NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 905 filers reported holding NOVARTIS A G in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,503,000 | -72.5% | 19,040 | -71.2% | 3.43% | -18.3% |
| Q2 2016 | $5,464,000 | +37.9% | 66,223 | +21.1% | 4.20% | +63.8% |
| Q1 2016 | $3,961,000 | -19.5% | 54,676 | -4.4% | 2.56% | -12.7% |
| Q4 2015 | $4,923,000 | -12.7% | 57,213 | -6.7% | 2.93% | -11.7% |
| Q3 2015 | $5,636,000 | -26.0% | 61,315 | -20.8% | 3.32% | -15.2% |
| Q2 2015 | $7,617,000 | +2.1% | 77,457 | +2.4% | 3.92% | -1.8% |
| Q1 2015 | $7,458,000 | -16.3% | 75,630 | -21.3% | 3.99% | -0.8% |
| Q4 2014 | $8,906,000 | -29.5% | 96,114 | -28.4% | 4.02% | -17.5% |
| Q3 2014 | $12,641,000 | +3.1% | 134,291 | -0.9% | 4.88% | +13.9% |
| Q2 2014 | $12,264,000 | +8.4% | 135,474 | +1.8% | 4.28% | +4.4% |
| Q1 2014 | $11,316,000 | -12.3% | 133,100 | -17.1% | 4.10% | -11.3% |
| Q4 2013 | $12,898,000 | +3.8% | 160,469 | -0.9% | 4.62% | -3.0% |
| Q3 2013 | $12,423,000 | +3.7% | 161,954 | -4.4% | 4.76% | +2.5% |
| Q2 2013 | $11,982,000 | – | 169,450 | – | 4.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |